All Stories

  1. The acronym "MSC" should stand for mesenchymal stem cells based on experimental evidience
  2. IP6K1 Reduces Mesenchymal Stem/Stromal Cell Fitness and Potentiates High Fat Diet-Induced Skeletal Involution
  3. Mesenchymal stromal cells and ischemic heart disease: hitting the target?
  4. Concise Review: MSC-Derived Exosomes for Cell-Free Therapy
  5. Rapid Generation of miRNA Inhibitor Leads by Bioinformatics and Efficient High-Throughput Screening Methods
  6. Reconciling the stem cell and paracrine paradigms of mesenchymal stem cell function
  7. Mesenchymal Stem Cells Yield Transient Improvements in Motor Function in an Infant Rhesus Macaque with Severe Early-Onset Krabbe Disease
  8. A Clinical Indications Prediction Scale Based on TWIST1 for Human Mesenchymal Stem Cells
  9. Quantifiable Metrics for Predicting MSC Therapeutic Efficacy
  10. Isolation of Mouse Bone Marrow Mesenchymal Stem Cells
  11. Small Molecule Inhibition of miR-544 Biogenesis Disrupts Adaptive Responses to Hypoxia by Modulating ATM-mTOR Signaling
  12. Pharmacological repression of PPARγ promotes osteogenesis
  13. MSCs: Scientific Support for Multiple Therapies
  14. Mesenchymal stem cells as cellular vectors for pediatric neurological disorders
  15. Allo-Reactivity of Mesenchymal Stem Cells in Rhesus Macaques Is Dose and Haplotype Dependent and Limits Durable Cell Engraftment In Vivo
  16. Mesenchymal Stem Cell Biodistribution, Migration, and HomingIn Vivo
  17. MSCs: science and trials
  18. The peculiar biology of mouse mesenchymal stromal cells—oxygen is the key
  19. Mesenchymal stromal cells: misconceptions and evolving concepts
  20. The Promise of Cell Therapy: Is History Repeating Itself
  21. MSCs: Paracrine Effects
  22. MicroRNAs in the ImprintedDLK1-DIO3Region Repress the Epithelial-to-Mesenchymal Transition by Targeting the TWIST1 Protein Signaling Network
  23. Therapeutic Applications of Mesenchymal Stem Cells
  24. Therapeutic Applications of Mesenchymal Stem Cells
  25. Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy
  26. Atmospheric Oxygen Inhibits Growth and Differentiation of Marrow-Derived Mouse Mesenchymal Stem Cells via a p53-Dependent Mechanism: Implications for Long-Term Culture Expansion
  27. Limited Acquisition of Chromosomal Aberrations in Human Adult Mesenchymal Stromal Cells
  28. Fibroblast Growth Factor 2 (Fgf2) Inhibits Differentiation of Mesenchymal Stem Cells by Inducing Twist2 and Spry4, Blocking Extracellular Regulated Kinase Activation, and Altering Fgf Receptor Expression Levels
  29. Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency
  30. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II
  31. Twist, Epithelial-to-Mesenchymal Transition, and Stem Cells
  32. High-capacity assay to quantify the clonal heterogeneity in potency of mesenchymal stem cells
  33. Cell-dose−dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs
  34. Defining the risks of mesenchymal stromal cell therapy
  35. Activation of CD74 inhibits migration of human mesenchymal stem cells
  36. In Vitro High-Capacity Assay to Quantify the Clonal Heterogeneity in Trilineage Potential of Mesenchymal Stem Cells Reveals a Complex Hierarchy of Lineage Commitment
  37. Small-Molecule Antagonist of Macrophage Migration Inhibitory Factor Enhances Migratory Response of Mesenchymal Stem Cells to Bronchial Epithelial Cells
  38. Migratory response of mesenchymal stem cells to macrophage migration inhibitory factor and its antagonist as a function of colony-forming efficiency
  39. A SAGE View of Mesenchymal Stem Cells
  40. Adipose Stromal/Stem Cells: Basic and Translational Advances: The IFATS Collection
  41. Marrow Stem Cells
  42. Isolation of Mesenchymal Stem Cells from Murine Bone Marrow by Immunodepletion
  43. Reprogramming Battle: Egg Vs. Virus
  44. Biochemical Heterogeneity of Mesenchymal Stem Cell Populations: Clues to their Therapeutic Efficacy
  45. Age- and Dose-Related Effects on MSC Engraftment Levels and Anatomical Distribution in the Central Nervous Systems of Nonhuman Primates: Identification of Novel MSC Subpopulations That Respond to Guidance Cues in Brain
  46. Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair-Current Views
  47. Cytoplasmic Extracts from Adipose Tissue Stromal Cells Alleviates Secondary Damage by Modulating Apoptosis and Promotes Functional Recovery Following Spinal Cord Injury
  48. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells
  49. Review:Ex VivoEngineering of Living Tissues with Adult Stem Cells
  50. Review:Ex VivoEngineering of Living Tissues with Adult Stem Cells
  51. Preclinical Evaluation of Adult Stem Cell Engraftment and Toxicity in the CNS of Rhesus Macaques
  52. Murine Mesenchymal Stem Cells Transplanted to the Central Nervous System of Neonatal Versus Adult Mice Exhibit Distinct Engraftment Kinetics and Express Receptors That Guide Neuronal Cell Migration
  53. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis
  54. Gene Expression Profiles of Mesenchymal Stem Cells
  55. Biological Activities Encoded by the Murine Mesenchymal Stem Cell Transcriptome Provide a Basis for Their Developmental Potential and Broad Therapeutic Efficacy
  56. Murine mesenchymal and embryonic stem cells express a similar Hox gene profile
  57. Plasticity and Therapeutic Potential of Mesenchymal Stem Cells in the Nervous System
  58. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection
  59. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects
  60. Building a consensus regarding the nature and origin of mesenchymal stem cells
  61. MicroSAGE Analysis of 2,353 Expressed Genes in a Single Cell-Derived Colony of Undifferentiated Human Mesenchymal Stem Cells Reveals mRNAs of Multiple Cell Lineages
  62. Pathogenesis of HIV-1 Infection Within Bone Marrow Cells
  63. Potential use of marrow stromal cells as therapeutic vectors for diseases of the central nervous system
  64. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells
  65. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate
  66. Enhanced In Situ Detection of β-Glucuronidase Activity in Murine Tissue
  67. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: Variations in yield, growth, and differentiation
  68. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: Variations in yield, growth, and differentiation
  69. A 1,064 bp fragment from the promoter region of the Col11a2 gene drives lacz expression not only in cartilage but also in osteoblasts adjacent to regions undergoing both endochondral and intramembranous ossification in mouse embryos
  70. Complex Genetic Organization of junB: Multiple Blocks of Flanking Evolutionarily Conserved Sequence at the Murine and Human junB Loci
  71. Regulation of expression by divalent cations of a light-inducible gene in Arthrobacter photogonimos
  72. Are ‘light-derepressible’ genes controlled by metal-protein complexes?
  73. Induction of a light-inducible gene in Arthrobacter sp. by exposure of cells to chelating agents and pH 5
  74. Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systems
  75. Synthesis of unsymmetrical 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones for antineoplastic evaluation